{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:32:52Z","timestamp":1789471972173,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>JIA-associated uveitis (JIAU) is a serious, sight-threatening disease with significant long-term complications and risk of blindness, even with improved contemporary treatments. The MIWGUC was set up in order to propose specific JIAU activity and response items and to validate their applicability for clinical outcome studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The group consists of 8 paediatric rheumatologists and 7 ophthalmologists. A consensus meeting took place on November 2015 in Barcelona (Spain) with the objective of validating the previously proposed measures. The validation process was based on the results of a prospective open, international, multi-centre, cohort study designed to validate the outcome measures proposed by the initial MIWGUC group meeting in 2012. The meeting used the same Delphi and nominal group technique as previously described in the first paper from the MIWGUC group (Arthritis Care Res 64:1365\u201372, 2012). Patients were included with a diagnosis of JIA, aged less than 18\u2009years, and with active uveitis or an uveitis flare which required treatment with a disease-modifying anti-rheumatic drug. The proposed outcome measures for uveitis were collected by an ophthalmologist and for arthritis by a paediatric rheumatologist. Patient reported outcome measures were also measured.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 82 patients were enrolled into the validation cohort. Fifty four percent (<jats:italic>n<\/jats:italic>\u2009=\u200944) had persistent oligoarthritis followed by rheumatoid factor negative polyarthritis (<jats:italic>n<\/jats:italic>\u2009=\u200915, 18%). The mean uveitis disease duration was 3.3\u2009years (SD 3.0). Bilateral eye involvement was reported in 65 (79.3%) patients.<\/jats:p>\n<jats:p>The main findings are that the most significant changes, from baseline to 6\u2009months, are found in the AC activity measures of cells and flare. These measures correlate with the presence of pre-existing structural complications and this has implications for the reporting of trials using a single measure as a primary outcome. We also found that visual analogue scales of disease activity showed significant change when reported by the ophthalmologist, rheumatologist and families.<\/jats:p>\n<jats:p>The measures formed three relatively distinct groups. The first group of measures comprised uveitis activity, ocular damage and the ophthalmologists\u2019 VAS. The second comprised patient reported outcomes including disruption to school attendance. The third group consisted of the rheumatologists\u2019 VAS and the joint score.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We propose distinctive and clinically significant measures of disease activity, severity and damage for JIAU. This effort is the initial step for developing a comprehensive outcome measures for JIAU, which incorporates the perspectives of rheumatologists, ophthalmologists, patients and families.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12969-019-0345-2","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T18:10:23Z","timestamp":1569953423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)"],"prefix":"10.1186","volume":"17","author":[{"given":"Ivan","family":"Foeldvari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Klotsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Simonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Edelsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila T.","family":"Angeles-Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regitze","family":"Bangsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Brumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Bou","family":"Torrent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Constantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"DeLibero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Maria","family":"Gerloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Heiligenhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisu","family":"Kotaniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasco","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Miserocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Niewerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Pontikaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Garcia","family":"de Vicuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Zilhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"issue":"9","key":"345_CR1","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/acr.21674","volume":"64","author":"A Heiligenhaus","year":"2012","unstructured":"Heiligenhaus A, Foeldvari I, Edelsten C, Smith JR, Saurenmann RK, Bodaghi B, et al. Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood. Arthritis Care Res (Hoboken). 2012;64(9):1365\u201372.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"12","key":"345_CR2","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1002\/acr.23224","volume":"69","author":"AJW Haasnoot","year":"2017","unstructured":"Haasnoot AJW, Sint Jago NFM, Tekstra J, de Boer JH. Impact of uveitis on quality of life in adult patients with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2017;69(12):1895\u2013902.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"10","key":"345_CR3","doi-asserted-by":"publisher","first-page":"e0164312","DOI":"10.1371\/journal.pone.0164312","volume":"11","author":"AJ Haasnoot","year":"2016","unstructured":"Haasnoot AJ, Vernie LA, Rothova A, P VDD, Los LI, Schalij-Delfos NE, et al. Impact of juvenile idiopathic arthritis associated uveitis in early adulthood. PLoS One. 2016;11(10):e0164312.","journal-title":"PLoS One"},{"issue":"8","key":"345_CR4","first-page":"1107","volume":"77","author":"T Constantin","year":"2018","unstructured":"Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis. 2018;77(8):1107\u201317.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"345_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/acr.23610","volume":"71","author":"Sheila T. Angeles\u2010Han","year":"2019","unstructured":"Angeles-Han ST, Lo MS, Henderson LA, Lerman MA, Abramson L, Cooper AM, et al. Childhood arthritis and rheumatology research Alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis. Arthritis Care Res (Hoboken). 2019;71(4):482\u201391.","journal-title":"Arthritis Care & Research"},{"issue":"17","key":"345_CR6","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","volume":"376","author":"AV Ramanan","year":"2017","unstructured":"Ramanan AV, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot-Lacassagne S, et al. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med. 2017;376(17):1637\u201346.","journal-title":"N Engl J Med"},{"issue":"11","key":"345_CR7","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/acr.23783","volume":"71","author":"Jennifer J. Y. Lee","year":"2019","unstructured":"Lee JJY, Duffy CM, Guzman J, Oen K, Barrowman N, Rosenberg AM, et al. Prospective determination of the incidence and risk factors of new-onset uveitis in juvenile idiopathic arthritis: the research in arthritis in Canadian children emphasizing outcomes cohort. Arthritis Care Res (Hoboken). 2018. \nhttps:\/\/doi.org\/10.1002\/acr.23783\n\n. epub 2018.2018\/10\/16","journal-title":"Arthritis Care & Research"},{"issue":"4","key":"345_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.autrev.2005.09.011","volume":"5","author":"AT Borchers","year":"2006","unstructured":"Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME. Juvenile idiopathic arthritis. Autoimmun Rev. 2006;5(4):279\u201398.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"345_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0039-6257(03)00084-5","volume":"48","author":"K Kotaniemi","year":"2003","unstructured":"Kotaniemi K, Savolainen A, Karma A, Aho K. Recent advances in uveitis of juvenile idiopathic arthritis. Surv Ophthalmol. 2003;48(5):489\u2013502.","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"345_CR10","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.ophtha.2006.05.016","volume":"113","author":"LI Kump","year":"2006","unstructured":"Kump LI, Castaneda RA, Androudi SN, Reed GF, Foster CS. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology. 2006;113(10):1874\u20137.","journal-title":"Ophthalmology."},{"issue":"6","key":"345_CR11","first-page":"936","volume":"33","author":"C Tappeiner","year":"2015","unstructured":"Tappeiner C, Klotsche J, Schenck S, Niewerth M, Minden K, Heiligenhaus A. Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis:data from a cross-sectional analysis of a prospective nationwide study. Clin Exp Rheumatol. 2015;33(6):936\u201344.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"345_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13023-019-1108-3","volume":"14","author":"AL Solebo","year":"2019","unstructured":"Solebo AL, Barry RJ, Keane PA, Rahi JS, Denniston AK. Under-utilisation of reproducible, child appropriate or patient reported outcome measures in childhood uveitis interventional research. Orphanet J Rare Dis. 2019;14(1):125.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"345_CR13","doi-asserted-by":"publisher","first-page":"e1000393","DOI":"10.1371\/journal.pmed.1000393","volume":"8","author":"IP Sinha","year":"2011","unstructured":"Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011;8(1):e1000393.","journal-title":"PLoS Med"},{"issue":"Suppl 3","key":"345_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","volume":"18","author":"PR Williamson","year":"2017","unstructured":"Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET handbook: version 1.0. Trials. 2017;18(Suppl 3):280.","journal-title":"Trials."},{"issue":"2","key":"345_CR15","first-page":"198","volume":"25","author":"M Boers","year":"1998","unstructured":"Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol. 1998;25(2):198\u20139.","journal-title":"J Rheumatol"},{"issue":"3","key":"345_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature working G. standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509\u201316.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"345_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/BOR.0000000000000316","volume":"28","author":"ST Angeles-Han","year":"2016","unstructured":"Angeles-Han ST, Rabinovich CE. Uveitis in children. Curr Opin Rheumatol. 2016;28(5):544\u20139.","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"345_CR18","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/acr.22627","volume":"67","author":"ST Angeles-Han","year":"2015","unstructured":"Angeles-Han ST, Yeh S, McCracken C, Jenkins K, Stryker D, Myoung E, et al. Using the effects of Youngsters\u2019 eyesight on quality of life questionnaire to measure visual outcomes in children with uveitis. Arthritis Care Res (Hoboken). 2015;67(11):1513\u201320.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"345_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.2042-7174.1996.tb00844.x","volume":"4","author":"J Cantrill","year":"1996","unstructured":"Cantrill J, B S, Buetow S. The Delphi and nominal group techniques in health services research. Int J Pharm Pract. 1996;4:67\u201374.","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"345_CR20","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"12","key":"345_CR21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/art.1780371209","volume":"37","author":"G Singh","year":"1994","unstructured":"Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37(12):1761\u20139.","journal-title":"Arthritis Rheum"},{"key":"345_CR22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/art.10095","volume":"46","author":"JW Varni","year":"2002","unstructured":"Varni JW, SEid M, Smith Knight T, Burwinkle T, Brown J, Szer IS. The PedsQL in pediatric Rheuamtology. Arthritis Rheum. 2002;46:714\u201325.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"345_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1037\/1082-989X.2.1.64","volume":"2","author":"D Hedeker","year":"1997","unstructured":"Hedeker D, Gibbons R. Application of random-effects pattern-mixture models forMissing data in longitudinal studies. Psychol Methods. 1997;2(1):64\u201378.","journal-title":"Psychol Methods"},{"issue":"11","key":"345_CR24","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31(11):2290\u20134.","journal-title":"J Rheumatol"},{"issue":"7","key":"345_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2017-212089","volume":"77","author":"P Quartier","year":"2018","unstructured":"Quartier P, Baptiste A, Despert V, Allain-Launay E, Kon\u00e9-Paut I, Belot A, et al. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Ann Rheum Dis. 2018;77(7):1003\u201311.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"345_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ophtha.2018.09.043","volume":"126","author":"Dyfrig A. Hughes","year":"2019","unstructured":"Hughes DA, Culeddu G, Plumpton CO, Wood E, Dick AD, Jones AP, et al. Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis. Ophthalmology. 2019;126,415\u201324.","journal-title":"Ophthalmology"},{"key":"345_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13023-015-0318-6","volume":"10","author":"AK Denniston","year":"2015","unstructured":"Denniston AK, Holland GN, Kidess A, Nussenblatt RB, Okada AA, Rosenbaum JT, et al. Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis. Orphanet J Rare Dis. 2015;10:97.","journal-title":"Orphanet J Rare Dis."},{"issue":"68","key":"345_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21680","volume":"21","author":"H Squires","year":"2017","unstructured":"Squires H, Poku E, Bermejo I, Cooper K, Stevens J, Hamilton J, et al. A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults. Health Technol Assess. 2017;21(68):1\u2013170.","journal-title":"Health Technol Assess"},{"issue":"1","key":"345_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/art.23248","volume":"59","author":"N Ruperto","year":"2008","unstructured":"Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, et al. The provisional Paediatric rheumatology international trials organisation\/American College of Rheumatology\/European league against rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum. 2008;59(1):4\u201313.","journal-title":"Arthritis Rheum"},{"key":"345_CR30","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"EH Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40:1202\u20139.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"345_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00296-016-3593-1","volume":"37","author":"E Pato","year":"2017","unstructured":"Pato E, Martin-Martinez MA, Castello A, Mendez-Fernandez R, Munoz-Fernandez S, Cordero-Coma M, et al. Development of an activity disease score in patients with uveitis (UVEDAI). Rheumatol Int. 2017;37(4):647\u201356.","journal-title":"Rheumatol Int"}],"updated-by":[{"DOI":"10.1186\/s12969-019-0396-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000}}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0345-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-019-0345-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-019-0345-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T23:25:01Z","timestamp":1601421901000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-019-0345-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["345"],"URL":"https:\/\/doi.org\/10.1186\/s12969-019-0345-2","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12969-019-0396-4","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication of the original article [1], we have been notified that the author Joan Calzada should not have been included to the team of authors. The authors\u2019 team, thus, should be as follows:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethic committee of the Aerztekammer Hamburg approved the study and the study was also approved at all participating sites. All parents gave their informed consent at the participating centres.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}